JEMPERLI

DOSTARLIMAB · GlaxoSmithKline LLC

Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for JEMPERLI, covering 2021-04-22 to 2026-06-10. Get the full timeline:

Most recent: EMA Authorised: Jemperli (dostarlimab) — GlaxoSmithKline Trading Services Limited